4AB:FRA
AbbVie Common Stock
233,10 €
arrow_upward
+1,30%(+3,00) 1D
2 қаз., 22:00:00 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
230,00 €
High
233,10 €
Low
230,00 €
Mkt. cap
464,43 млрд
Avg. vol.
47,00
Volume
5,00
52-wk high
235,70 €
52-wk low
167,55 €
No. of employees
57 мың
Open
230,00 €
High
233,10 €
Low
230,00 €
Mkt. cap
464,43 млрд
Avg. vol.
47,00
Volume
5,00
52-wk high
235,70 €
52-wk low
167,55 €
No. of employees
57 мың
News stories
From web sources and news partners
AD HOC NEWS
·
5 сағат бұрын
AbbVie declares a quarterly dividend as AbbVie stock trades flat at EUR 233.55
Insider Monkey
·
17 сағат бұрын
AbbVie (ABBV) vs Bristol Myers (BMY): Which is a Better Stock to Buy?
The Motley Fool
·
1 күн бұрын
AbbVie Just Won FDA Approval for a Once-Daily Parkinson's Pill. Here's Why It Matters More Than You Think.
MarketWatch
·
2 күн бұрын
AbbVie Inc. stock outperforms competitors on strong trading day
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57 мың
Founded2012 ж. 10 сәу.
HeadquartersNorth Chicago, Иллинойс, Америка Құрама Штаттары
Sector-
Websiteabbvie.com